Výsledky vyhledávání - "long acting injectable"

Akademický článek

Earlier Use of Long-Acting Injectable Paliperidone Palmitate Once-Monthly versus Oral Antipsychotics in Patients with Schizophrenia: An Integrated Patient-Level Meta Analysis of the PROSIPAL and PRIDE Studies

Autor: Sajatovic M, Doring M, Lopena OJ, Johnston K, Turkoz I, Josiah N, Obando C

Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 2227-2235 (2024)

Martha Sajatovic,1 Monica Doring,2 Oliver J Lopena,2 Karen Johnston,2 Ibrahim Turkoz,3 Nia Josiah,4 Camilo Obando2 1University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA; 2Janssen Scient

Externí odkaz: https://doaj.org/article/de2db74823384aed9e263892cbaa6ede

Zobrazit plný text záznamu

Akademický článek

Introducing S.C.O.P.E.™ (Schizophrenia Clinical Outcome Scenarios and Patient–Provider Engagement), an Interactive Digital Platform to Educate Healthcare Professionals on Schizophrenia Care

Autor: Correll CU, Rubio JM, Citrome L, Mychaskiw MA, Thompson S, Franzenburg KR, Suett M, Kotak S, Kane JM

Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 1995-2010 (2024)

Christoph U Correll,1– 4,* Jose M Rubio,1– 3,* Leslie Citrome,5,* Marko A Mychaskiw,6 Stephen Thompson,6 Kelli R Franzenburg,7 Mark Suett,8 Sameer Kotak,9 John M Kane1– 3,* 1Department of Psychiatry, The Zucker Hillside Hospital

Externí odkaz: https://doaj.org/article/959f61b128e348409830ac5b7602f26d

Zobrazit plný text záznamu

Akademický článek

Health-Care Utilisation and Costs of Transition from Paliperidone Palmitate 1-Monthly to 3-Monthly Treatment for Schizophrenia: A Real-World, Retrospective, 24-Month Mirror-Image Study

Autor: Chang BC, Kuo MH, Lee CH, Chu YL, Chen KP, Tung CL, Yang YH, Hung CS, Tsai JH, Chuang HY

Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 1985-1993 (2024)

Bo-Chieh Chang,1 Meng-Hsuan Kuo,1 Chi-Hui Lee,1 Ya-Lan Chu,1 Kuang-Peng Chen,2 Chun-Liong Tung,2 Ya-Hui Yang,3 Chuan-Sheng Hung,4 Jui-Hsiu Tsai,2,5 Hung-Yi Chuang6 1Department of Pharmacy, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation,

Externí odkaz: https://doaj.org/article/af2f34c50d074448a59abcf8434a80c9

Zobrazit plný text záznamu

Akademický článek

TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia

Autor: Citrome L, Suett M, Franzenburg KR, Eshet R, Elgart A, Davis GL 3rd, Harary E, Tohami O, Mychaskiw MA, Kane JM

Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 1901-1917 (2024)

Leslie Citrome,1 Mark Suett,2 Kelli R Franzenburg,3 Roy Eshet,4 Anna Elgart,4 Glen L Davis 3rd,5 Eran Harary,4 Orna Tohami,4 Marko A Mychaskiw,6 John M Kane7– 9 1Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla,

Externí odkaz: https://doaj.org/article/4c8c119c36ed4df6ad5d5eb1cf734bc6

Zobrazit plný text záznamu

Akademický článek

Impact of Demographics and Insurance Coverage on Schizophrenia Treatment and Healthcare Resource Utilization Within an Integrated Healthcare System

Autor: Seo S, Healey BE, McLin R, Sacks NC, Benson CJ, Citrome L

Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 20, Pp 1837-1848 (2024)

Sanghyuk Seo,1 Bridget E Healey,2 Ronae McLin,2 Naomi C Sacks,2 Carmela J Benson,1 Leslie Citrome3 1Medical Affairs Neuroscience, Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Titusville, NJ, USA; 2PRECISIONheor, Boston, MA, USA; 3Dep

Externí odkaz: https://doaj.org/article/bcd40a22401b44bda3275a7e9af862a3

Zobrazit plný text záznamu

Akademický článek

Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system

Autor: Afiba Manza-A Agovi, Caitlin T. Thompson, Kevin J. Craten, Esther Fasanmi, Meng Pan, Rohit P. Ojha, Erika L. Thompson

Publikováno v: Implementation Science Communications, Vol 5, Iss 1, Pp 1-11 (2024)

Abstract Background Long-acting injectable cabotegravir plus rilpivirine (LAI CAB/RPV) has several potential benefits over daily oral formulations for HIV treatment, including the potential to facilitate long-term adherence and reduce pill fatigue. W

Externí odkaz: https://doaj.org/article/00cf97ea2cd54d16bfcb2508621911db

Zobrazit plný text záznamu

Akademický článek

Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthcare System compared to daily oral HIV treatments

Autor: Laura-Amanda Vallejo Aparicio, Victoria Neches García, Beatriz Hernández-Novoa, Gregorio Casado, Ferrán Jodar, Marco Pinel, Daniel Callejo Velasco

Publikováno v: BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-9 (2024)

Abstract Introduction HIV treatment currently consists of daily oral antiretroviral therapy (ART). Cabotegravir + rilpivirine long-acting (CAB + RPV LA) is the first ART available in Spain administered every 2 months through intramuscular injection b

Externí odkaz: https://doaj.org/article/bbed26e2cce74f478f2a9a4614a0aee3

Zobrazit plný text záznamu

Akademický článek

Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV

Publikováno v: Frontiers in Pharmacology, Vol 15 (2024)

BackgroundThe pharmacokinetics of long-acting rilpivirine has mostly been studied in clinical trials, which do not fully address the uncertainties that arise in routine clinical situations.Aims and methodsOur population analysis aims to establish per

Externí odkaz: https://doaj.org/article/58665483a2d948d0a939985937ee8dc8

Zobrazit plný text záznamu

Akademický článek

Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China

Autor: Shiwen Chen, Yuhua Ruan, Lu Liu, Hengyan Pei, Yu Jiang, Tengda Huang, Yuxia Wei, Litai Qin, Xuebin Dai, Yu Liu, Junhui Liu, Yihong Xie

Publikováno v: Frontiers in Pharmacology, Vol 15 (2024)

ObjectivesThere is still no study focused on willingness to pay for long-acting injectable cabotegravir (CAB-LA) after it was available on the market in the United States in 2021. Here, we explored the willingness to pay for CAB-LA and associated fac

Externí odkaz: https://doaj.org/article/1a21384cc7554082be4d6e18f36e79ac

Zobrazit plný text záznamu

Akademický článek

Barriers to long‐acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey

Autor: Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando

Publikováno v: Neuropsychopharmacology Reports, Vol 44, Iss 2, Pp 417-423 (2024)

Abstract Aims To investigate the negative attitudes of Japanese psychiatrists toward atypical long‐acting injectable (LAI) antipsychotics, which are the current mainstream LAIs in Japan. Methods We surveyed 69 Japanese psychiatrists using a 5‐poi

Externí odkaz: https://doaj.org/article/e5e3a299efdd4bc5b7d29bbd5b5d2c47

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání